Friday, September 5 – Deputy Premier and Minister of Health Sylvia Jones launched Ontario’s Health Innovation Pathway yesterday, creating the first systematic route for medical devices, digital health products, and care delivery innovations to reach scaled adoption in the provincial health system. The goal is to scale up innovative health technology adoption through the pathway’s streamlined system. The pathway includes $12 million in immediate project funding through the Health Technology Accelerator Fund.
The first four pilot projects are:
- Wound Care Management ($5M) – Digital measurement tools and advanced dressings to reduce lower limb amputations
- AI-Powered Diabetic Retinopathy Screening ($1.5M) – Early detection to prevent diabetes-induced vision loss
- Computer-Assisted Surgical Navigation ($5M) – Hip and knee surgery precision systems to reduce revision operations
- Abdominal Wall Surgical Supports ($500K) – Non-invasive, post-surgery care options
The pathway involves coordination across five ministries and agencies: Ontario Health, Supply Ontario, the Ministry of Health, the Ministry of Economic Development, Job Creation and Trade, and the Ministry of Public and Business Service Delivery and Procurement. Ontario Health will serve as the single point of contact for technology submissions, while Supply Ontario handles procurement coordination.
The pathway will accept submissions for medical devices, digital health technologies, medical and surgical procedures, imaging and screening programs, lab and genetic testing, and care delivery models.
Santis Insights
The Health Innovation Pathway represents the resurrection of a concept that survived multiple government transitions. In 2015, the Liberal government created an Office of the Chief Innovation Strategist to provide “white glove support” for companies scaling in Ontario’s health system. In 2017, the Progressive Conservatives scrapped it, but COVID-19 supply chain disruptions renewed government focus on domestic innovation capacity. The Health Technology Accelerator Fund was announced in the 2024 budget, and today’s launch completes the infrastructure.
This is bigger than another government funding announcement. Ontario has solved a fundamental market failure that has constrained health innovation investment for years. Unlike pharmaceuticals, which have a clear pathway to formulary decisions, medical devices and digital health solutions have faced uncertain, ad hoc procurement approaches. Companies had no clear route from innovation to sustainable government adoption, which killed the incentive to develop Ontario-focused solutions.
The pathway creates the missing infrastructure. Now, companies have consistent intake processes, dedicated funding mechanisms, and streamlined procurement coordination. The pathway solves the classic “valley of death” problem where promising innovations die between development and market sustainability.
Why This Matters Now
COVID-19 was the game changer. Supply chain disruptions demonstrated the value of domestic production capabilities and proved that procurement nationalism is politically sustainable. The “made-in-Ontario” preference is no longer economic development rhetoric but rather strategically necessary policy. This matters because it leverages Ontario’s substantial health purchasing power to build domestic industrial capacity while shielding Canada from an increasingly nationalistic world.
The distributed approach across five ministries and agencies is smarter than the previous centralized Chief Innovation Strategist model. Rather than creating a single point of failure, innovation support is now embedded across multiple government functions. This should prove more resilient to political changes while maintaining streamlined vendor engagement through Ontario Health.
The Real Test
The clincher isn’t whether these four pilot projects clinically succeed – it’s whether Ontario Health can effectively manage the intake process and establish clear timelines for second-round selections. The hard part is delivering transparent evaluation timelines, consistent decision criteria, and viable routes from pilot funding to scaled adoption across Ontario’s health system.
The risks? Ontario Health’s effectiveness as the single point of contact for submissions will also make or break this initiative. The distributed coordination structure creates potential bottlenecks despite promises of streamlined experience.
What’s Next
Industry engagement levels over the coming months will reveal market confidence in the new processes, particularly from companies that have been burned by previous government innovation promises.
Success here could position Ontario as a preferred testing ground for health innovation and potentially drive increased venture capital investment in provincial health technology companies.
Watch for the development of post-pilot scaling mechanisms and seamless integration with existing health system procurement processes.
The pathway’s ultimate value lies in building sustainable bridges from innovation to implementation across Ontario’s health system, not just funding interesting projects that never reach meaningful scale.
Further Reading
Read the official announcement here.
Technology proposals can be submitted here.
Ontario’s Life Sciences Strategy details can be found here.